clinical trial management system (CTMS)
In the evolving landscape of clinical trials, CTMS plays a pivotal role. It facilitates enhanced productivity, provides detailed insights from data, and upholds strict compliance standards, offering a holistic solution for trial management.
What is a Clinical Trial Management System (CTMS)?
Clinical trials help establish the safety and effectiveness of drugs or medical devices in patients. A Clinical Trial Management System (CTMS) is any software used to manage end-to-end clinical trial activities, including setup, preparation, conduct, monitoring, and closeout.
Benefits of a CTMS
Improve trial efficiency through standardization, tracking, and data analytics.
1. Increase Productivity
As your organization grows, so does the complexity and number of trials, which entails sophisticated document, financial, and resource management. A CTMS provides user-friendly interfaces and one centralized repository for all study information, which reduces the need for data re-entry. Study teams can link the same information entered once to different milestones, risks, and tasks.
2. Enable Data-Driven Decisions
With customizable and insightful reporting, Clinical Operations can monitor key metrics (such as site enrollment status, patient enrollment, and completed subjects) to develop actionable insights. Furthermore, higher data visibility gives sponsors the real-time trial status, cutting down on avoidable delays in waiting for study team members or the CRO to provide critical information.
3. Enhance Transparency
Many CTMS solutions can integrate with EDC, safety databases, and ePRO. As a web-based platform, a CTMS not only frees itself from physical constraints of storing large amounts of trial data, but also accelerates remote data entry, access, and processing.
4. Improve Compliance
Due to concurrent studies and numerous sites, oversight of all trials is a daunting task. CTMS feature workflow automation, which reduces human error and ensures continued, timely execution of trial processes. By standardizing workflows within the system, organizations can ensure that users consistently follow in-house guidelines, trial protocols, and the latest regulations.
Key CTMS Capabilities
A robust CTMS platform should support most of the following processes:
Study Planning & Oversight
- Assess study milestones (ex: first patient in, last patient out) via user-friendly interface.
- Reference operational data of historical trials in a centralized repository.
- Send automatic notifications to CRAs when site visits are almost due.
Subject Recruitment
- Plan subject recruitment at the study, study country, and site levels.
- Analyze reports on patient recruitment and retention against predefined targets.
- View subject enrollment in real-time.
Site Monitoring
- Manage pre-study, site initiation, interim monitoring, and closeout activities remotely.
- Develop operational metrics dashboard for onsite monitoring.
- Trace protocol deviation creation, revision, and finalization via audit trails.
Risk & Issue Management
- Capture protocol deviations, issues, and follow-up items.
- Implement risk assessments and mitigation.
- Create reports to track KPIs and resolution turnaround time.
Popular CTMS Systems
There are numerous CTMS vendors in the life sciences space, all of which generally provide milestone tracking, workflow automation, and visual analytics. Below, we’ve listed some solutions that our clients use:
- Rave CTMS (Medidata, Dassault Systemes): End-to-end cloud-based platform featuring intelligent risk detection and bidirectional information transfer with Rave eTMF.
- Siebel CTMS (Oracle): Trial management suite that improves data quality and risk analysis at both study and portfolio levels; can be integrated with advanced analytics capabilities.
- Trial Interactive CTMS (TransPerfect): Mobile-first 360° platform that offers integrations with TI’s site feasibility, study start-up, eTMF, LMS, content management, and collaboration solutions.
- Vault CTMS (Veeva Systems): Adopted by hundreds of organizations, Vault CTMS can consolidate with other applications in the Vault Clinical Operations Suite: EDC, Study Start Up, Payments, and Veeva Site Connect.
Our Approach to Clinical Trial Management Systems
Business Requirements
CTMS solutions are not one-size-fits-all. Determine which features are nice-to-have, and which ones are critical for your organization. For example, if a high degree of...
Read MoreBusiness Requirements
CTMS solutions are not one-size-fits-all. Determine which features are nice-to-have, and which ones are critical for your organization. For example, if a high degree of customization and data migration tools are must-haves, confirm that potential vendors will support those needs.
Read LessBudget
CTMS should be viewed as an investment. Licensing, system support, and subscription fees may be continuing costs that should be compared against your department’s budget. Consider how pricing...
Read MoreBudget
CTMS should be viewed as an investment. Licensing, system support, and subscription fees may be continuing costs that should be compared against your department’s budget. Consider how pricing may change as you add more studies and system users.
Read LessTimeline
Consider each vendor’s proposed implementation timeline against the time constraints of your company. If your first study site activation is in two months, narrow consideration down to...
Read MoreTimeline
Consider each vendor’s proposed implementation timeline against the time constraints of your company. If your first study site activation is in two months, narrow consideration down to vendors who can complete the project in that timeframe.
Read LessComplexity
Purchasing a CTMS is an investment not only of money, but also of time and effort. Regardless of organization size, it is a challenge to manage clinical trial data (a responsibility...
Read MoreComplexity
Purchasing a CTMS is an investment not only of money, but also of time and effort. Regardless of organization size, it is a challenge to manage clinical trial data (a responsibility traditionally managed by CROs). How much training will your staff need to learn the system properly? Additionally, factor in your team’s adaptability and buy-in when selecting a particular solution.
Read LessCompliance
Does the CTMS software meets all requirements imposed by HIPAA, GDPR, and 21 CFR Part 11? Assess the vendor’s agility in releasing new features to support evolving regulations.
Read MoreCompliance
Does the CTMS software meets all requirements imposed by HIPAA, GDPR, and 21 CFR Part 11? Assess the vendor’s agility in releasing new features to support evolving regulations.
Read LessProPharma: Your Organization’s Preferred Partner
ProPharma's R&D Technology team understands the criticality of selecting the right CTMS and excels in aligning your companies’ needs with regulations and GxP system best practices. Our comprehensive approach and expert knowledge ensure that your organization is set up for long-term success. Our team has extensive experience in the following areas:
Service Category |
How We Can Help |
Strategy & Business Process Optimization |
|
Regulatory Operations |
|
Implementation Support |
|
Validation |
|
Managed Services |
|
Clinical Trial Management System Experts
If you are interested in implementing or optimizing CTMS, ProPharma's R&D Technology team comprises experienced consultants who can advise your digital transformation. If you are interested in partnering with ProPharma on any of the services above, contact us via the form below. We look forward to working with you!
Subscribe for Updates
News & Insights
May 10, 2024
FDA Publishes Guidance for CAR T Products
In January 2024, the FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products issued a guidance document- Considerations for the Development of Chimeric Antigen Receptor...
May 8, 2024
Mandatory HTAR Implementation in the EU: Part 2
How ProPharma Can Help You Ensure Compliance with the New HTAR Requirements The new Health Technology Assessment Regulation (HTAR) will set new requirements for pharmaceutical companies seeking...
May 2, 2024
Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable RALEIGH, May 2, 2024 – ProPharma, the leading global provider of regulatory, clinical,...
April 18, 2024
ProPharma Now Certified as Medidata Rave EDC Accredited Partner
Leading Research Consulting Organization (RCO) Receives Medidata Accreditation for the RAVE EDC Module, Enhancing Clinical Trial Efficiency and Data Integrity for sponsors. RALEIGH, April 18, 2024 –...
November 27, 2023
EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist
Entrepreneur Of The Year® celebrates ambitious entrepreneurs who are building a better world. RALEIGH, NC, November 27, 2023 – Ernst & Young LLP (EY US) today announced that Chief Executive Officer,...
October 11, 2023
ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023
Raleigh, NC, October 11, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...
August 15, 2023
ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies
ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...
June 10, 2022
The Cost of Poor Project Management
Project Management isn’t for the faint of heart. There is a shockingly high rate of project failure… but on the other hand, great project management can be a key differentiator that leads a company...
August 31, 2022
Successfully Passing MHRA Inspections for Overseas Manufacturing Sites
ProPharma offers GMP and GDP compliance services from clinical development to commercial distribution of the products' lifecycle. ProPharma’s Compliance and Quality team completed the first on-site...
News & Insights
May 2, 2024
Revolutionizing Patient Care: ProPharma and PBL Launch Innovative Cell & Gene Therapy Manufacturing Device
First-of-its-kind Cell Factory Box streamlines production, making advanced treatments accessible and affordable RALEIGH, May 2, 2024 – ProPharma, the leading global provider of regulatory, clinical,...
April 18, 2024
ProPharma Now Certified as Medidata Rave EDC Accredited Partner
Leading Research Consulting Organization (RCO) Receives Medidata Accreditation for the RAVE EDC Module, Enhancing Clinical Trial Efficiency and Data Integrity for sponsors. RALEIGH, April 18, 2024 –...
November 27, 2023
EY Announces Michael Stomberg as an Entrepreneur Of the Year® 2023 National Finalist
Entrepreneur Of The Year® celebrates ambitious entrepreneurs who are building a better world. RALEIGH, NC, November 27, 2023 – Ernst & Young LLP (EY US) today announced that Chief Executive Officer,...
October 11, 2023
ProPharma Group Recognized by Everest Group as a Major Contender in Life Sciences Operations PEAK Matrix® Assessment 2023
Raleigh, NC, October 11, 2023: ProPharma Group (ProPharma), the leading global provider of regulatory, clinical and compliance services for the life sciences industry, and a portfolio company of...
August 15, 2023
ProPharma Recognized by Inc. 5000 List of America’s Fastest-Growing Companies
ProPharma Recognized on the Inc. 5000 List of America’s Fastest-Growing Companies After a year of Growth and Innovation, ProPharma achieved its highest rank in 20+ year history. RALEIGH, NC, August...
May 10, 2024
FDA Publishes Guidance for CAR T Products
In January 2024, the FDA Center for Biologics Evaluation and Research (CBER) Office of Therapeutic Products issued a guidance document- Considerations for the Development of Chimeric Antigen Receptor...
May 8, 2024
Mandatory HTAR Implementation in the EU: Part 2
How ProPharma Can Help You Ensure Compliance with the New HTAR Requirements The new Health Technology Assessment Regulation (HTAR) will set new requirements for pharmaceutical companies seeking...